In this line, we found that AGAP1, CCAR1 and SH3PXD2B are significantly higher expressed in HCC compared to normal tissue and (i) positively correlate with PRAME expression in tumor tissue of available HCC patient data and (ii) high expression of each interaction partner associates with poorer survival probability. This evidence concerns the gene PRAME and hepatocellular carcinoma.